Biotia

The patients we serve have often been told their symptoms don't match their results. We start from the position of listening to the patient when they tell us something is wrong. Our tests are designed to get them one step closer to understanding the root cause of their symptoms.

We build every claim on what the evidence supports, and stop there. We qualify uncertainty. We explain limits. We invest in and publish basic and clinical research studies in peer-reviewed journals to build trust in our products.

A diagnostic result that can't be understood is a missed opportunity. We build our reports to be clear, concise, and clinically actionable so that patients and providers understand the results and are able to do something about them.

Biotia builds cutting-edge diagnostic technology to address infections standard testing was never designed for. Every decision about what we test for, who we partner with, and what we claim follows from one commitment: to be genuinely useful to the patient.

The U.S. healthcare system is deeply inequitable. As such, Biotia is intent on ensuring our diagnostics tests are designed for the gaps in care the system produces. This includes working to obtain insurance reimbursement and expanding access to our diagnostics through partnerships with clinics, hospitals, and telehealth providers.